We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Expresses Concerns on Generic Topical Patches
Industry Expresses Concerns on Generic Topical Patches
Earlier this summer the FDA recommended a five-point scale to measure topical patch adhesion for drugmakers submitting ANDAs. However, the recommendations have only raised more questions.